← Leaderboards
Robert Pagels
Optimeos Life Sciences, Inc.
$1,697,833
Attributed
$1,981,000
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NSF$1,981,000 · 3
By mechanism
—$1,981,000 · 3
Top collaborators
- Robert K Prud'Homme2 shared
- Rodney D Priestley1 shared
Grant awards (3)
SBIR Phase II: Formulation of a mRNA-Based Therapy for CTLN1 by Inverse Flash NanoPrecipitation$1,500,000
· FY2023 · TIP · contact PI
STTR Phase I: Formulation of a COVID-19 mRNA Vaccine by Inverse Flash NanoPrecipitation$256,000
· FY2020 · TIP · contact PI
STTR Phase I: Sustained Delivery of Peptides with Inverse Flash Nanoprecipitation$225,000
· FY2019 · TIP · contact PI